Stoke Therapeutics shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $2.9M | 254k | 11.35 |
| 2025-03-31 | $1.7M | 254k | 6.65 |
| 2024-12-31 | $2.8M | 254k | 11.03 |
| 2024-09-30 | $5.2M | 427k | 12.29 |
| 2024-06-30 | $5.8M | 427k | 13.51 |
| 2024-03-31 | $5.8M | 427k | 13.50 |
| 2023-12-31 | $5.7M | 1.1M | 5.26 |
| 2023-09-30 | $4.3M | 1.1M | 3.94 |
| 2023-06-30 | $12M | 1.1M | 10.63 |
| 2023-03-31 | $9.1M | 1.1M | 8.33 |
| 2022-12-31 | $10M | 1.1M | 9.23 |
| 2022-09-30 | $14M | 1.1M | 12.84 |
| 2022-06-30 | $14M | 1.1M | 13.21 |
| 2022-03-31 | $23M | 1.1M | 21.05 |
| 2021-12-31 | $28M | 1.2M | 23.99 |
| 2021-09-30 | $33M | 1.3M | 25.44 |
| 2021-06-30 | $43M | 1.3M | 33.66 |
| 2021-03-31 | $56M | 1.4M | 38.84 |
| 2020-12-31 | $89M | 1.4M | 61.93 |
| 2020-09-30 | $52M | 1.5M | 33.49 |
| 2020-06-30 | $41M | 1.7M | 23.83 |
| 2020-03-31 | $39M | 1.7M | 22.90 |
| 2019-12-31 | $51M | 1.8M | 28.32 |
| 2019-09-30 | $38M | 1.8M | 21.49 |
| 2019-06-30 | $55M | 1.9M | 29.17 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management